Treatment-resistant depression and major depression with suicide risk-The cost of illness and burden of disease

Funding The present work received support from Janssen-Cilag Farmacêutica, Lda, as an Unrestricted Grant. Janssen-Cilag had no role in the execution of the study, including analyses and interpretation of results.

Detalhes bibliográficos
Autor principal: Sousa, Rute Dinis (author)
Outros Autores: Gouveia, Miguel (author), Nunes da Silva, Catarina (author), Rodrigues, Ana Maria (author), Cardoso, Graça (author), Antunes, Ana Filipa (author), Canhao, Helena (author), de Almeida, José Miguel Caldas (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
burden of disease
cost of illness
disability-adjusted life years (DALYs) lost
major depression with suicide risk
treatment-resistant depression
SDG 3 - Good Health and Well-being
Texto completo:http://hdl.handle.net/10362/143631
País:Portugal
Oai:oai:run.unl.pt:10362/143631

Texto Completo

http://hdl.handle.net/10362/143631

Registros relacionados